Affiliation:
1. Department of Physiology and Biomedical Engineering Mayo Clinic Rochester Minnesota USA
2. Department of Health Sciences Research Division of Biomedical Statistics and Informatics Mayo Clinic‐Rochester Rochester Minnesota USA
3. Department of Radiology Mayo Clinic‐Rochester Rochester Minnesota USA
4. Department of Neurology Mayo Clinic‐Rochester Rochester Minnesota USA
Abstract
AbstractINTRODUCTIONAge‐related and Alzheimer's disease (AD) dementia–related neurodegeneration impact brain health. While morphometric measures from T1‐weighted scans are established biomarkers, they may be less sensitive to earlier changes. Neurite orientation dispersion and density imaging (NODDI), offering biologically meaningful interpretation of tissue microstructure, may be an advanced brain health biomarker.METHODSWe contrasted regional gray matter NODDI and morphometric evaluations concerning their correlation with (1) age, (2) clinical diagnosis stage, and (3) tau pathology as assessed by AV1451 positron emission tomography.RESULTSOur study hypothesizes that NODDI measures are more sensitive to aging and early AD changes than morphometric measures. One NODDI output, free water fraction (FWF), showed higher sensitivity to age‐related changes, generally better effect sizes in separating mild cognitively impaired from cognitively unimpaired participants, and stronger associations with regional tau deposition than morphometric measures.DISCUSSIONThese findings underscore NODDI's utility in capturing early neurodegenerative changes and enhancing our understanding of aging and AD.Highlights
Neurite orientation dispersion and density imaging can serve as an effective brain health biomarker for aging and early Alzheimer's disease (AD).
Free water fraction has higher sensitivity to normal brain aging.
Free water fraction has stronger associations with early AD and regional tau deposition.
Funder
National Institutes of Health
GHR Foundation
Mayo Foundation for Medical Education and Research